Adient Plc Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Adient Plc on November 17, 2022. The filing addresses Item 5.02 regarding the appointment of certain officers and compensatory arrangements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on executive compensation adjustments.
Material Changes
On November 17, 2022, the Human Capital and Compensation Committee approved a Restricted Stock Unit (RSU) award for Jerome J. Dorlack. Key details include:
- Role Change: Mr. Dorlack, currently Executive Vice President, Americas, will become Executive Vice President and Chief Financial Officer (CFO) effective December 1, 2022.
- Compensation Adjustment: The award replaces 10% of one year's salary that Mr. Dorlack will forfeit due to a salary reduction.
- Award Value: The grant date fair value equals 10% of his salary as in effect at the time of grant (December 1, 2022).
- Vesting: The award vests on the one-year anniversary of the grant date, subject to continued vesting upon involuntary termination without cause or accelerated vesting upon death or disability.
Management Commentary and Risks
Management stated that the salary reduction and replacement RSU award are intended to align pay with performance and align the interests of the CFO with those of Adient's shareholders. The terms mirror those previously approved for the President and CEO, as disclosed in a September 22, 2022, Form 8-K. No specific risks or contingencies were detailed in this filing.
Investor Verification Checklist
- Verify the exact salary amount used to calculate the 10% RSU grant value.
- Review the September 22, 2022, Form 8-K to confirm the specific terms of the Restricted Shares or Restricted Share Unit Award Agreement.
- Confirm the effective date of the CFO transition (December 1, 2022).